ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 316 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $537 | +37.0% | 20 | +81.8% | 0.00% | – |
| Q2 2023 | $392 | +40.5% | 11 | 0.0% | 0.00% | – |
| Q1 2023 | $279 | -37.4% | 11 | 0.0% | 0.00% | – |
| Q4 2022 | $446 | – | 11 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 11 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 11 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 11 | -42.1% | 0.00% | – |
| Q2 2021 | $2,000 | +100.0% | 19 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | -50.0% | 19 | -38.7% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 31 | -3.1% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 32 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 32 | +33.3% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 24 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | – | 24 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,303 | $54,386,000 | 28.54% |
| JOHNSON & JOHNSON | 3,260,869 | $216,196,000 | 24.61% |
| ACT CAPITAL MANAGEMENT, LLC | 210,500 | $13,956,000 | 10.09% |
| Aquilo Capital Management, LLC | 700,426 | $46,438,000 | 5.27% |
| WEALTH EFFECTS LLC | 145,960 | $9,677,000 | 4.02% |
| Evolutionary Tree Capital Management, LLC | 115,580 | $7,663,000 | 3.68% |
| ACUTA CAPITAL PARTNERS, LLC | 105,500 | $6,995,000 | 2.94% |
| Privium Fund Management B.V. | 204,393 | $13,766,000 | 2.73% |
| L1 Capital Pty Ltd | 292,735 | $19,408,000 | 2.24% |
| Avidity Partners Management LP | 875,000 | $58,013,000 | 1.23% |